Barbara Ryan, Director at MiNK Therapeutics, Inc. (INKT), sold 2,500 shares at $10.17 ($36K) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Seasonal sale ($36k) by Director — this insider has traded INKT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.17 | 200 | $2K | 5.6% |
| 2 | $10.17 | 200 | $2K | 5.6% |
| 3 | $15.28 | 300 | $5K | 12.6% |
| 4 | $15.28 | 300 | $5K | 12.6% |
| 5 | $15.30 | 500 | $8K | 21.0% |
| 6 | $15.57 | 500 |
| $8K |
| 21.3% |
| 7 | $15.57 | 500 | $8K | 21.4% |
| Total | $14.58 avg | 2,500 | $36K | 100% |
| Filing → |
| INDV | BUY | 2026-03-11 | $1K | — | Filing → |
| INKT | SELL | 2026-03-04 | $5K | — | Filing → |
| INDV | BUY | 2026-01-07 | $27K | — | Filing → |